AMREF and AstraZeneca launch mobile clinics to widen COVID-19 vaccination reach in Kenya

The initiative will help ensure those in remote areas are afforded access to COVID-19 vaccines.



The African Medical and Research Foundation (AMREF) Health Africa had partnered with British pharma giant AstraZeneca as well as the Ministry of Health (MoH) in Kenya to launch a fleet of Mobile Vaccination Clinics (MVCs) aimed at protecting last-mile communities from the COVID-19 pandemic. Supported by ten mobile clinics, the initiative is expected to help increase access to COVID-19 vaccines along with other health services across hard-to-reach communities across the East African nation. Each of the ten MVCs is expected to vaccinate between 70 and 100 people per day, reaching up to 1,000 people per day once all 10 units are fully operational. The clinics are seen as instrumental tools towards bridging the COVID-19 vaccine gap across immunities typically left on the periphery.


“It is evident that health emergencies are here to stay, and thinking out of the box through innovations in health may be our only chance at timely response if, and when emergencies occur. Addressing other health determinants such as non-communicable diseases that influence how health emergencies affect us is critical to avert the negative impact that health emergencies such as COVID-19 have on communities. The movable clinics are, therefore, a great addition to the toolkit that will ensure equity in access to last-mile communities with much-needed vaccination and essential health services,” said Dr. Githinji Gitahi, Group CEO Amref Health Africa. According to Dr Pelin Incesu, Area Vice President, AstraZeneca for the Middle East and Africa, the innovative partnership will help ensure no Kenyan is left behind in the fight against COVID-19 and other life-threatening diseases.